arrow
J

Julen Oyarzábal

centro de investigacion medica aplicada
H指数:44
被引数:6,921

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1
2024-11-021
OAAI
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
2024-07-022
OAAI
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks
2021-09-0114
OAAI
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
2021-06-1832
PREAI
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma
2021-03-0416
PREAI
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
2021-01-1832
OAAI
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
2020-12-1847
OA
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis
2020-08-0619
OAAI
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
2019-08-2335
PREAI
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
2019-07-03138
PREAI
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
2019-04-0124
PREAI